FDA-approved drugs for AD mainly include donepezil, rivastigmine, galantamine, and tacrine (AChE inhibitors); memantine (N-methyl-D-aspartate (NMDA) antagonist); and aducanumab (amyloid-β aggregation inhibitor). Here, ACHE is linked to Alzheimer disease.